American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
-
Am J Health Syst Pharm · Aug 2020
ReviewIntranasal esketamine: A novel drug for treatment-resistant depression.
To review the efficacy, safety, and place in therapy of intranasal esketamine, a treatment modality for treatment-resistant depression. ⋯ Patients with moderate to severe depression who are not sufficiently responsive to traditional strategies for managing TRD may benefit from adjunctive esketamine therapy.